Decline in activities of daily living in the rarer dementias

Beatrice Taylor, Suraya Mohamud, Emilie Brotherhood, Emma Harding, Claire Waddington, Paul M. Camic, Daniel C. Alexander, Sebastian J. Crutch, Joshua Stott, Chris Jd Hardy, Neil P. OxtobyGeneral 2025 · DOI

TL;DR

This review synthesizes existing research on how daily living activities decline in rarer forms of dementia, which often present with atypical symptoms and earlier onset than Alzheimer's disease. The findings highlight significant heterogeneity in decline patterns across these conditions, underscoring the need for more specific diagnostic and staging tools to improve care and support for affected individuals and their caregivers.

What Problem Does This Paper Address?

Dementia is a broad clinical syndrome characterized by progressive cognitive decline. While Alzheimer's disease (AD) is the most common form, accounting for 50-75% of diagnoses, a significant portion of individuals are affected by "rarer dementias." These are defined as conditions making up less than 10% of diagnoses, excluding typical AD and vascular dementia. Rarer dementias often present with unusual symptoms, earlier onset (before age 65), and can be genetically inherited. This group includes Frontotemporal Dementia (FTD) and its subtypes (like behavioral variant FTD, semantic PPA, non-fluent/agrammatic PPA), and Posterior Cortical Atrophy (PCA).

A critical aspect of managing any dementia is understanding the decline in Activities of Daily Living (ADLs), which encompass basic self-care (eating, dressing) and instrumental tasks (managing finances, cooking). While staging scales exist for typical AD to track ADL decline, there's a significant knowledge gap regarding how these activities deteriorate in rarer dementias. This lack of specific information makes it challenging to anticipate care needs, plan interventions, and conduct clinical trials effectively for these less common, yet often more burdensome, conditions. This paper aims to address this gap by systematically reviewing the available literature on ADL decline in rarer dementias.

Methods

The authors conducted a systematic review of the global literature. They searched five major databases (MEDLINE, Embase, Emcare, PsycINFO, and CINAHL) using keywords related to "rarer dementias," "activities of daily living," and "longitudinal or cross-sectional studies." The search was conducted up to September 2021, following a predefined protocol registered with PROSPERO.

Studies were included if they focused on dementias with less than 10% prevalence (including PPA variants, PCA, FTD variants, familial AD), primarily addressed ADLs (both basic and instrumental), were longitudinal or cross-sectional, had a minimum sample size of five, and were published in English. Studies on typical AD, vascular dementia, Lewy body dementia, or non-neurodegenerative conditions were excluded.

A three-step screening process (title, abstract, full text) was employed, with a random 10% double-checked by an independent reviewer. Relevant data was extracted, including study design, sample size, duration, ADL measurement tools, and reported ADL decline sequences and rates. Quality assessment of the included studies was also performed using an adapted tool.

Datasets

Not discussed in the paper. The paper is a systematic review of existing literature, not an empirical study that collected or analyzed new data from specific datasets.

Key Insights and Ideas

  • Heterogeneity is the Rule: The most striking finding is the significant variability in how ADLs decline across different rarer dementias, and even within subtypes of the same dementia. This suggests that a one-size-fits-all approach to ADL assessment and care planning is insufficient.
  • Mismatch in Assessment Tools: Many studies used ADL assessment tools developed for typical Alzheimer's disease (e.g., Disability Assessment for Dementia - DAD). While useful, these tools may not fully capture the unique symptom profiles and early functional impairments seen in rarer dementias, potentially leading to underestimation of decline or misinterpretation of symptoms.
  • Need for Variant-Specific Scales: The review strongly advocates for the development of staging scales that are tailored to specific dementia variants. Such scales would provide more accurate descriptions of functional decline, enabling better prediction of care needs and more effective treatment planning.
  • Impact on Caregivers: Rarer dementias, often affecting younger individuals, place unique stresses on caregivers due to genetic susceptibility, employment, and family responsibilities. Understanding ADL decline is crucial for empowering caregivers with practical and emotional preparation.
  • Under-representation of PCA: While the majority of studies focused on the FTD/PPA spectrum, only one study addressed PCA, highlighting a significant gap in research for this variant.

Key Results

  • Study Selection: Out of 579 retrieved studies, 20 met the inclusion criteria. Of these, 19 focused on the FTD/PPA spectrum, and one on PCA.
  • Study Design: 16 studies were longitudinal (median duration of 2.2 years), and 4 were cross-sectional.
  • Participant Numbers: A total of 3309 participants were included across the studies.
  • ADL Measurement: The Disability Assessment for Dementia (DAD) was the most common tool, used in 8 studies.
  • Varied Decline Sequences: The literature reported diverse sequences of ADL decline. For example, in FTD, bathing, grooming, and toileting declined faster than in tAD, while dressing and eating were better preserved. In bvFTD, IADLs generally declined before BADLs.
  • Rate of Decline: Some studies suggested that the rate of ADL decline could be faster in rarer dementias compared to tAD.
  • Limited Representation: Most studies had small sample sizes, with only three exceeding 100 individuals for any single dementia variant. Early-onset dementias and their specific care needs were not well-represented.

Limitations and Future Work

Limitations: * Heterogeneity of Studies: The review encompassed various dementia types and subtypes, making direct comparisons challenging. * Combination of Study Designs: The inclusion of both cross-sectional and longitudinal studies prevented a meta-analysis. * Minor Study Shortcomings: Some included studies had minor limitations, such as incomplete follow-up in longitudinal designs, which could affect the depiction of decline. * Insufficient Demographic Data: Limited demographic information in some studies hindered the assessment of participant representativeness. * Lack of Variant-Specific Tools: The reliance on ADL measures developed for tAD may not be optimal for capturing the nuances of rarer dementias.

Future Work: * Develop Variant-Specific Staging Scales: Create comprehensive, variant-specific ADL staging scales that cover the entire disease course from diagnosis to end-of-life. * Investigate Neuropsychological Links: Explore the specific relationships between neuropsychological profiles (e.g., executive function) and ADL decline in rarer dementias. * Utilize Emerging Technologies: Employ wearable technology and other emerging research methods to gather richer, more objective, and frequent ADL data. * Leverage Computational Models: Use larger datasets to develop statistical or computational models for deeper quantitative insights into ADL decline. * Qualitative Research: Incorporate inductive or qualitative methods to capture the lived experiences of individuals with rarer dementias and their caregivers, identifying meaningful milestones of impact. * Focus on Early Onset: Address the significant gap in research on early-onset dementias and their unique care needs.

Summary updated

Abstract

Rarer dementias are associated with atypical symptoms and younger onset, which result in a higher burden of care. We provide a review of the global literature on longitudinal decline in activities of daily living (ADLs) in dementias that account for less than 10% of dementia diagnoses. Published studies were identified through searches conducted in Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica Database (Embase), Excerpta Medica Care (Emcare), PsycINFO, and Cumulative Index in Nursing and Allied Health Literature (CINAHL). The search criteria included terms related to 'rarer dementias', 'activities of daily living' and 'longitudinal or cross-sectional studies' following a predefined protocol registered. Studies were screened, and those that met the criteria were citation searched. Quality assessments were performed, and relevant data were extracted. 20 articles were selected, of which 19 focused on dementias within the frontotemporal dementia/primary progressive aphasia spectrum, while one addressed posterior cortical atrophy. Four studies were cross-sectional and 16 studies were longitudinal, with a median duration of 2.2 years. The Disability Assessment for Dementia was used to measure decline in 8 of the 20 studies. The varied sequences of ADL decline reported in the literature reflect variation in diagnostic specificity between studies and within-syndrome heterogeneity. Most studies used Alzheimer's disease staging scales to measure decline, which cannot capture variant-specific symptoms. To enhance care provision in dementia, ADL scales could be deployed postdiagnosis to aid treatment and planning. This necessitates staging scales that are variant-specific and span the disease course from diagnosis to end of life. PROSPERO registration number: CRD42021283302.
BibTeX
@inproceedings{taylor2025decline,
  author = {Beatrice Taylor and Suraya Mohamud and Emilie Brotherhood and Emma Harding and Claire Waddington and Paul M. Camic and Daniel C. Alexander and Sebastian J. Crutch and Joshua Stott and Chris JD Hardy and Neil P. Oxtoby},
  title = {{Decline in activities of daily living in the rarer dementias}},
  booktitle = {General},
  year = {2025},
  doi = {10.1136/gpsych-2024-101905},
}
Figure